PARAMETRIC PORTFOLIO ASSOCIATES LLC - SANGAMO THERAPEUTICS INC ownership

SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 195 filers reported holding SANGAMO THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.58 and the average weighting 0.0%.

Quarter-by-quarter ownership
PARAMETRIC PORTFOLIO ASSOCIATES LLC ownership history of SANGAMO THERAPEUTICS INC
ValueSharesWeighting
Q1 2022$1,323,000
+22.4%
227,772
+58.0%
0.00%0.0%
Q4 2021$1,081,000
-20.9%
144,136
-4.9%
0.00%0.0%
Q3 2021$1,366,000
-33.8%
151,610
-12.1%
0.00%0.0%
Q2 2021$2,064,000
-8.8%
172,458
-4.5%
0.00%0.0%
Q1 2021$2,263,000
-36.1%
180,627
-20.5%
0.00%
-50.0%
Q4 2020$3,544,000
+62.0%
227,078
-1.9%
0.00%0.0%
Q3 2020$2,187,000
+16.6%
231,441
+10.6%
0.00%
+100.0%
Q2 2020$1,876,000
+73.4%
209,337
+23.2%
0.00%0.0%
Q1 2020$1,082,000
+37.7%
169,859
+81.0%
0.00%0.0%
Q4 2019$786,000
-13.5%
93,855
-6.6%
0.00%0.0%
Q3 2019$909,000
-7.9%
100,454
+9.6%
0.00%0.0%
Q2 2019$987,000
+22.0%
91,682
+8.1%
0.00%0.0%
Q1 2019$809,000
-22.7%
84,815
-7.0%
0.00%0.0%
Q4 2018$1,047,000
-44.0%
91,233
-17.3%
0.00%
-50.0%
Q3 2018$1,870,000
+2.0%
110,351
-14.6%
0.00%0.0%
Q2 2018$1,834,000
-47.5%
129,180
-29.7%
0.00%
-33.3%
Q1 2018$3,491,000
+55.6%
183,716
+34.3%
0.00%
+50.0%
Q4 2017$2,243,000
+422.8%
136,789
+378.5%
0.00%
Q3 2017$429,000
-25.8%
28,587
-74.3%
0.00%
-100.0%
Q1 2017$578,000
-32.9%
111,136
-25.3%
0.00%0.0%
Q2 2016$861,000
-6.5%
148,721
-2.3%
0.00%0.0%
Q1 2016$921,000152,1890.00%
Other shareholders
SANGAMO THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Golden State Equity Partners 154,360$897,0000.45%
Rhenman & Partners Asset Management AB 761,429$4,424,0000.44%
Lombard Odier Asset Management (Switzerland) SA 860,702$5,001,0000.39%
WASATCH ADVISORS LP 10,576,997$61,452,0000.30%
Rokos Capital Management LLP 977,663$5,861,0000.27%
KLK CAPITAL MANAGEMENT LLC 44,323$258,0000.26%
Long Focus Capital Management, LLC 340,000$1,975,0000.25%
Vanguard Capital Wealth Advisors 33,380$193,0000.14%
Fort Sheridan Advisors LLC 73,978$430,0000.13%
Delphia (USA) Inc. 20,983$122,0000.09%
View complete list of SANGAMO THERAPEUTICS INC shareholders